Loading...
Serum fibroblast growth factor 19 is decreased in patients with overt hypothyroidism and subclinical hypothyroidism
As a newly emerging metabolic regulator, accumulating evidence suggests that the circulating fibroblast growth factor 19 (FGF19) level correlated with lipid and glucose metabolism. Several independent groups have found that FGF19 was highly likely associated with multiple metabolic disorders. Thyroi...
Na minha lista:
| Udgivet i: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Wolters Kluwer Health
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5265952/ https://ncbi.nlm.nih.gov/pubmed/27684859 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005001 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|